Early treated mice showed a trend for higher increase of hind limb force and more improvement of MNCVs approaching those of age-matched WT mice, while in post-onset treated mice they remained significantly below those of WT mice.
← all excerpts
AAV9-mediated Schwann cell-targeted gene therapy rescues a model of demyelinating neuropathy.
1
—
—